Ceftaxon-TZ 1.125 Injection
Marketer
Medfence Labs
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftaxon-TZ 1.125 Injection
The injectable formulation Ceftaxon-TZ 1.125 combines medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be solely by a healthcare provider. Adherence to the prescribed schedule is crucial; completing the full course is essential, regardless of symptom improvement. Premature cessation may compromise its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before use. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote recovery. Your physician may order tests to monitor treatment efficacy.
Primary Ingredients of Ceftaxon-TZ 1.125 Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Ceftaxon-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Ceftaxon-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftaxon-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftaxon-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ceftaxon-TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, combined as Ceftaxon-TZ 1.125 Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a key antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to survive. Tazobactum, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Ceftaxon-TZ 1.125 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftaxon-TZ 1.125 is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Ceftaxon-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceftaxon-TZ 1.125 Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftaxon-TZ 1.125 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Ceftaxon-TZ 1.125 Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Ceftaxon-TZ 1.125 Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Ceftaxon-TZ 1.125 Injection :
Omit a Ceftaxon-TZ 1.125 Injection dose? Seek your physician's advice.
Facts to Know About Ceftaxon-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently